PharmTech News

Articles

Capsugel adds clinical trial and commercial manufacturing, as well as particle engineering services with two acquisitions.

Capsugel to Acquire Xcelience and Powdersize

Caroline Hroncich was associate editor for Pharmaceutical Technology, Pharmaceutical Technology Europe, and BioPharm International from 2015 to 2017.

Sanofi Pasteur was granted marketing authorization for Dengvaxia, the first vaccine for dengue fever.

Mexican Authorities Approve First Vaccine for Dengue

Catalent has entered into an exclusive long-term supply agreement to produce Pfizer’s OTC proton-pump inhibitor for heartburn treatment, Nexium 24HR (esomeprazole), which is also marketed as Nexium Control outside the US.

Catalent Secures Manufacturing Contract for Pfizer’s OTC Heartburn Treatment

Paragon Bioservices entered into a contract with the International Aids Vaccine Initiative for the process and analytical development and cGMP manufacturing of an HIV vaccine candidate.

Paragon Bioservices to Develop HIV Vaccine Candidate

The Committee on Energy and Commerce met to assess influenza vaccine effectiveness, and changes for the 2015-2016 season.

Committee on Energy and Commerce Assesses Influenza Vaccine Effectiveness

The goal is to have all of Novo Nordisk’s production plants operating on renewable electricity with zero CO2 emissions by 2020.

Novo Nordisk to Switch to Renewable Energy by 2020

Under the terms of the agreement, Xellia will acquire substantial parts of the Ben Venue site, including four sterile injectable manufacturing plants, which are not currently operational.

Hikma Sells Ben Venue Manufacturing Facilities to Xellia

The proposed merger of Pfizer and Allergan will create a new top drug maker and cut Pfizer’s tax bill with a headquarters move to Ireland.

Pfizer-Allergan Merger Valued at $160 Billion

Randi Hernandez was science editor at Pharmaceutical Technology from September 2014 to May 2017.

The increase in spending is said to be due to increased access to and use of medicines in emerging markets and higher prices for branded, specialty medications in developed markets.

IMS: Global Drug Spending to Increase 30% by 2020

Operations at Catalent’s Beinheim, France, softgel facility were suspended following suspected deliberate action to misplace capsules.

Top News